Pular para o conteúdo
Merck

FEM1 proteins are ancient regulators of SLBP degradation.

Cell cycle (Georgetown, Tex.) (2017-01-25)
John F Dankert, Julia K Pagan, Natalia G Starostina, Edward T Kipreos, Michele Pagano
RESUMO

FEM1A, FEM1B, and FEM1C are evolutionarily-conserved VHL-box proteins, the substrate recognition subunits of CUL2-RING E3 ubiquitin ligase complexes. Here, we report that FEM1 proteins are ancient regulators of Stem-Loop Binding Protein (SLBP), a conserved protein that interacts with the stem loop structure located in the 3' end of canonical histone mRNAs and functions in mRNA cleavage, translation and degradation. SLBP levels are highest during S-phase coinciding with histone synthesis. The ubiquitin ligase complex SCFcyclin F targets SLBP for degradation in G2 phase; however, the regulation of SLBP during other stages of the cell cycle is poorly understood. We provide evidence that FEM1A, FEM1B, and FEM1C interact with and mediate the degradation of SLBP. Cyclin F, FEM1A, FEM1B and FEM1C all interact with a region in SLBP's N-terminus using distinct degrons. An SLBP mutant that is unable to interact with all 4 ligases is expressed at higher levels than wild type SLBP and does not oscillate during the cell cycle. We demonstrate that orthologues of SLBP and FEM1 proteins interact in C. elegans and D. melanogaster, suggesting that the pathway is evolutionarily conserved. Furthermore, we show that FEM1 depletion in C. elegans results in the upregulation of SLBP ortholog CDL-1 in oocytes. Notably, cyclin F is absent in flies and worms, suggesting that FEM1 proteins play an important role in SLBP targeting in lower eukaryotes.

MATERIAIS
Número do produto
Marca
Descrição do produto

Sigma-Aldrich
Antiβ-actina monoclonal, clone AC-15, ascites fluid
Millipore
ANTI-FLAG®, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Anti-CTIF antibody produced in rabbit, affinity isolated antibody, buffered aqueous glycerol solution
Sigma-Aldrich
MISSION® esiRNA, targeting human FEM1C
Sigma-Aldrich
MISSION® esiRNA, targeting human FEM1B